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INTRODUCTION  
Superficial mycoses are most common worldwide. They 
are believed to affect 20%to25%of the world, s 
population and the incidence continues to increase
1
. 
They are  caused by dermatophytes. Topical creams and 
lotions, including ,  ketoconazole  shampoo or cream, 
selenium sulfide shampoo, terbinafine cream, and 
ciclopirox cream, are effective in treating Malassezia 
infections and are usually applied for 2 weeks
4.
Systemic 
antifungals like 400mg single dose of oral fluconazole, 
or Itraconazole/ketaconazole 200mg/day for 7 days are 
also effective.
1a
The  problem with the use of topical 
antifungal is the difficulty in applying cream or lotion to 
a wide body body surface area for longer period. While 
oral therapy is ideal for this condition which involves 
the stratum corneum. Patient prefers the convenience of 
oral antifungal therapy
5.
  So it has been decided to 
compare the efficacy of single dose of oral fluconazole 
with topical clotrimazole in patients with Pityriasis 
versicolor.
 
METHODOLOGY 
 
This study was conducted as Prospective, Randomized, 
open labeled, comparative study between November 
2011 to August 2012 in the Department of 
Dermatology, Stanley medical college with prior 
permission obtained with Institutional Ethics 
Committee. Good clinical practice was followed as per 
the Declaration of Helsinki .Sixty patients enrolled for 
the study with the following inclusion and exclusion 
criteria after obtaining written informed consent in their 
own language from those who were willing to 
participate in this study. 
Inclusion criteria 
 Age:18-60 years 
 Both sexes 
 Newly diagnosed patients with localized pityriasis 
versicolor 
 Patient seeking treatment for the first time. 
 Patient who were willing to give informed consent 
to the study. 
 Exclusion criteria  
 Patient with extensive lesion 
 Age below18years and above 60 years 
 Pregnant and lactating women 
 Patient with preexisting renal,liver andcardiac 
illness 
 Patient with known   history of taking antifungals 
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 Patients with immunocomparamised state      
A total number of 60 patients were enrolled  for the 
study.The patients were randomized and allotted into 
two groups with thirty patients in each groups. The 
groups were named as GROUP A and GROUP B .All 
the patient in Group A were treated  by applying 
clotrimazole ointment twice a day for a continuous 
period of two weeks . This group  is the CONTROL 
group while patients in GROUP B were treated with 
single dose of oral  fluconazole 400mg .This group is 
the STUDY group and the results of this group was 
compared with the control group.Treatment allocation is 
as follows. 
GroupA _ (Control) {30 patients_Topical clotrimazole 
twice a day for 2weeks} 
GroupB _ (Study) {30patients_Oral fluconazole single 
dose of 400 mg} 
EVALUATION AND FOLLOWUP 
The effectiveness of treatment was assessed by the 
following parameters. 
1. Clinical efficacy was assessed by the clearance of 
      a)Desquamation 
      b)Pigmentation 
At the end of 2
nd 
week , 4
th
week, 6
th
week. The patient 
were asked to return the empty tube during the follow 
up visit period. All the patients were asked to come for 
follow up at 12
th
 week 
 2. Mycological clearance was assessed by 
      a)Skin scraping with KOH mount 
      b)Fungal culture 
 At the beginning and at the end of the study . 
The biochemical parameters were assessed at the 
beginning and at the end of 2
nd
 week of treatment to 
evaluate any undesirable changes in the functions of the 
vital organs. 
RESULTS  
Demographic statistics: 
Age 
In our study the mean age of the patients of both the 
groups A & Bwere 30.03&30.33 respectively which 
was analysed statistically.There was no significant 
difference in the age distribution between the groups.  
Sex 
In our study sex distribution of the patients of group 
A& B were found to be equal. There was no significant 
difference between the two groups 
a) Desquamation 
The mean desquamation at base line  was .0.00 for both 
the group.By the end of two weeks the mean of group A 
was 0.83 & Group B was 0.77 which implies there was 
good improvement in desquamation with Group A 
compared with Group B .But the p value was not 
statistically significant which was 0.527 
From fourth week onwards the mean value was higher 
with Group B and at the end of sixth week the mean 
value of  Group B was 2.83 and in Group A it was2.40 
which showed that  there was good improvement in 
desquamation in Group B (P value <0.001) 
At the end of 12week of follow up the mean of Group B 
was 2.93 and mean of Group A was 2.57 which was 
statistically significant implies that there was 
statistically significant improvement with oral 
fluconazole (P value <0.001) 
 
Table 1: Shows the degree of desquamation between study groups 
Desqumation Topical clotrimazole Oral fluconazole P value  
  Mean SD Mean SD 
Baseline 0.00 0.000 0.00 0.000 _ 
2
nd
 week 0.83 0.379 0.77 0.430 0.527 
4
th 
week 1.80 0.484 2.20 0.407 0.001 
6
th
 week 2.40 0.498 2.83 0.379 <0.001 
12
th
 week 2.57 0.504 2.93 0.254 <0.001 
* P≤0.05 significant  , ** P≤0.01 highly significant  , *** P≤0.001 very high   significant 
b) Pigmentation 
Similarly in pigmentation also mean  baseline was  0.00  
for both the groups.By the end of second week the mean 
value of pigmentation in Group A was 0.67 & mean of 
GroupB was 0.47 which  implies there was good 
improvement in pigmentation in GroupA compared 
with GroupB.But the p value was not statistically  
significant which was 0.12. But from fourth week 
onwards the mean improvement in pigmentation was 
greater in GroupB compared with GroupA and also 
statistically significant. 
At the end of sixth week the mean of Group A was1.83; 
and Group B was 2.67 
(P <0.001) implies there was good improvement in 
pigmentation with oral fluconazole.   
At the end of 12 week the mean of pigmentation in 
GroupB was2.80 when compared with GroupA which 
showed the mean 2.03(p<0.001) implies during the 
follow up visit also oral fluconazole showed good 
improvement. 
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Table 2: Shows the degree of pigmentation between study groups 
Pigmentation Topical clotrimazole Oral fluconazole P value  
  Mean SD Mean SD 
Baseline 0.00 0.000 0.00 0.000 _ 
2
nd
 week 0.67 0.479 0.47 0.507 0.122 
4
th 
week 1.13 0.346 1.80 0.407 <0.001 
6
th
 week 1.83 0.379 2.67 0.479 <0.001 
12
th
 week 2.03 0.414 2.80 0.407 <0.001 
* P≤0.05 significant  , ** P≤0.01 highly significant  , *** P≤0.001 very high   significant   
 
Mycological assessment 
Mycological cure which was assessed by skin scraping 
&fungal culture. Skin scraping and fungal culture was 
negative in both the groups at the end of the study.   
Thus overall results of our study showed though  topical 
clotrimazole  showed  better  reduction  in desquamation 
&pigmentation at the end of second week,  the results 
were  not statistically significant. Mycological cure was 
almost similar to oral fluconazole but clinical cure was 
less compared with oral fluconazole. 
Cost effectiveness; 
Pharmacoeconomically single dose of oral fluconazole is 
cost benefit to the patientscompared to the 2week course 
of topical clotrimazole. 
DISSCUSION 
a) Desquamatiion 
The mean desquamation at base line was .0.00 for both 
the groups. By the end of two weeks the mean of 
GroupA was 0.83 & GroupB was 0.77 which implies 
there was good improvement in desquamation with 
Group A compared with Group B .But the p value was 
not statistically significant which was 0.527 
From fourth week onwards the mean value was higher 
with Group B and at the end of sixth week the mean 
value of  GroupB was 2.83 and in Group A it was2.40 
which showed that  there was good improvement in 
desquamation in GroupB (P value <0.001) 
At the end of 12week  the mean of Group B was 2.93 
and  mean of Group A was 2.57 which was statistically 
significant implying that there was statistically 
significant improvement with oral fluconazole (P value 
<0.001) 
c) Pigmentation 
Similarly in pigmentation also mean baseline was 0.00 
for both the groups. By the end of second week the mean 
value of pigmentation in Group A was 0.67 & mean of 
Group B was 0.47 which implies that there was good 
improvement in pigmentation in Group A compared with 
Group B. But the p value was not statistically significant 
which was 0.122 
But from fourth week onwards the mean improvement in 
pigmentation was greater in Group B compared with 
Group A and also statistically significant p value. 
(p<0.001) 
At the end of sixth week the mean of Group A was1.83; 
and Group B was 2.67 
(P <0.001) impliying there was good improvement in 
pigmentation with oral fluconazole.   
 At the end of 12 week the mean of pigmentation 
in GroupB was2.80 when compared with Group A which 
showed a mean of 2.03(p<0.001) impliying during the 
follow up visit also oral fluconazole showed good 
improvement. 
Mycological assessment 
Mycological cure which was assessed by skin scraping 
&fungal culture .Skin scraping and fungal culture was 
negative in both the groups at the end of the study.   
Thus the overall results of our study showed that though 
topical clotrimazole showed better reduction in 
desquamation &pigmentation at the end of second week, 
the results were not statistically significant. Mycological 
cure was almost similar to oral fluconazole but clinical 
cure was less compared with oral fluconazole at the end 
of study. 
Cost effectiveness; 
Pharmacoeconomically single dose of oral fluconazole is 
cost of benefit to the patients compared to the 2week 
course of topical clotrimazole. 
Compliance; 
As fluconazole is single oral dose, the compliance is 
good with this group. 
The other drawbacks of topical therapy is 
 Difficulty in applying cream or lotion to a wide 
surface area twice daily for a continuous period of 
two weeks. 
 Pharmacoeconomically, the treatment regimen is 
costlier compared with that of single dose of oral 
fluconazole. 
 Patients compliance is also less with this therapy 
CONCLUSION  
Oral fluconazole therapy was found to be superior than 
topical clotrimazole in the treatment of pityriasis 
versicolor in terms of efficacy and patient compliance 
and also cost effective for the patients  
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